Rubin Minhas. Show Affiliations »
Abstract
Mesh： See more » Cost SavingsDrug CostsDrug Industry/economicsDrug Industry/legislation & jurisprudenceDrugs, Generic/economicsEvidence-Based MedicineHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/economicsHypolipidemic Agents/economicsPatents as Topic/legislation & jurisprudence
Substances： See more » Drugs, GenericHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents
Year: 2007 PMID： 17229171 DOI： 10.1111/j.1742-1241.2006.01248.x
Source DB: PubMed Journal: Int J Clin Pract ISSN： 1368-5031 Impact factor: 2.503